If you're looking for a solution to optimize solid-state formulations and reduce the risk of surprises in drug development, Lavo Life Sciences offers a robust AI-accelerated crystal structure prediction system. This system uses AI algorithms to predict crystal structures with high accuracy, speeding up the process and minimizing risk. It can analyze millions of potential crystal structures in days and accounts for environmental factors like temperature and pressure, helping to optimize drug formulations for better stability and manufacturability.
Another noteworthy solution is Genesis Therapeutics, which provides an AI-based platform called GEMS. While not exclusively focused on solid-state formulations, GEMS combines deep learning and molecular simulations to predict properties and generate molecules. This platform helps researchers design first- and best-in-class small molecule drugs, which can indirectly contribute to optimizing drug formulations by identifying novel chemical spaces that are less likely to cause formulation issues.